WILL KEEP EYES ON THIS 1.. I LIKE THE BALANCE SHEET GROWTH.. P/E IS BIT HIGH .WILL WAIT FOR FURTHER DROP
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market